Back label with the Supplement Facts panel

Zoom

Formula panel: Shatavari root powder and extracts, Ashoka bark extract and black pepper extract

Make Periods Easier Again panel on menstrual comfort, with statistics on period pain

Six ways HerB™ supports women’s wellness

60 · Vegan

HerB™ Capsules

Name: HerB™ Capsules
Brand: Adisutra
Price: 1395.00 INR
Availability: InStock

Shatavari and Ashoka bark, to help regulate cycles and ease monthly discomfort, naturally.

₹1,395

60 vegan capsules · 60 servings

Purchase

One-time purchase₹1,395

Subscribe & Save15% off every order₹1,395₹1,186

30-day assurance · Free shipping above ₹499

Supports hormonal balanceHelps support natural hormonal harmony.
Supports reproductive healthNourishes and strengthens women’s reproductive wellness.
Helps regulate menstrual cycleSupports regular, healthy cycles.
Promotes menstrual comfortHelps ease monthly discomfort naturally.
Nourishes from withinPowerful herbs that nourish and support women’s wellness holistically.
Gentle and plant-basedPlant-based, clean and gentle for everyday use.

Shatavari root powder295 mg
Ashoka bark extract200 mg
Shatavari root extract125 mg
Shatavari root extract125 mg
Black pepper extract5 mg

Full composition

Suggested serving: 1 capsule (750 mg) · 60 servings per bottle

Delivery estimate

Delivery pincode

Enter your pincode to see estimated delivery dates

Make Periods Easier Again

Ādisūtra’s HerB™ blends standardised Shatavari (5% shatavarins I–IV) with a 40% saponins extract, so every active compound, not just one, works toward hormonal balance and reproductive strength. Ashoka bark, standardised to 5% tannins, supports uterine tone and comfort. Together, they help regulate cycles and ease monthly discomfort, naturally.

The label, in full

One serving is 1 capsule (750 mg). Every bottle holds 60 capsules, 60 servings.

shatavarins I–IV: 5%
Shatavari saponins: 40%
Ashoka bark tannins: 5%

GMO free
Vegan
Standardised extracts
Plant-based HPMC capsule

Supplement FactsServing size 1 capsule (750 mg)Servings per container 60
Ingredient	Amount per serving
Shatavari root powderAsparagus racemosus	295 mg
Ashoka bark extractSaraca indica · 5% tanninsSupports uterine tone and comfort.	200 mg
Shatavari root extractAsparagus racemosus · 5% shatavarins I–IVWorks with the 40% extract toward hormonal balance and reproductive strength.	125 mg
Shatavari root extractAsparagus racemosus · 40% saponins	125 mg
Black pepper extractPiper nigrum · 95% extract	5 mg
Other ingredients: Capsule shell, plant-based (HPMC)

Complete women’s wellness support

Supports hormonal balance
Helps support natural hormonal harmony.
Supports reproductive health
Nourishes and strengthens women’s reproductive wellness.
Helps regulate menstrual cycle
Supports regular, healthy cycles.
Promotes menstrual comfort
Helps ease monthly discomfort naturally.
Nourishes from within
Powerful herbs that nourish and support women’s wellness holistically.
Gentle and plant-based
Plant-based, clean and gentle for everyday use.

Research

Research on this product

Evidence strengthModerate

Moderate for Shatavari; Ashoka is backed by traditional Ayurvedic use.

Supported by 6 double-blind RCTs with 554 participants, all published 2024-2026, including 2 on the same 5% total-shatavarin standardization.

Human RCTs: 6; 2 on the same 5% standardization (284 participants)
Participants in RCTs: 554
Other studies: None

See all research

Studies

6 studies

Mishra et al. (2026)ARova5X
Avicenna J Phytomed 2026;16(5):860-872
View study: Mishra et al. (2026), opens in a new tab
Exact ingredient: Shatavari 5% extract · Exact match (standardization and daily dose)
Versus placebo, the extract improved sexual-function domains including desire, arousal and satisfaction; vaginal lubrication improved by 84.11% in the extract group versus 13.08% on placebo, and oxidative-stress markers and menopausal symptoms such as hot flashes, fatigue and irritability also improved.
- RCT, double-blind
- n=214
- 5% shatavarins
- 250 mg/day
- 90 days
Full summary
A randomized, double-blind, placebo-controlled trial in 214 postmenopausal women (107 per group) tested a hydroalcoholic Shatavari root extract standardized to 5% shatavarins at 250 mg/day for 90 days. Versus placebo, the extract improved sexual-function domains including desire, arousal and satisfaction; vaginal lubrication improved by 84.11% in the extract group versus 13.08% on placebo, and oxidative-stress markers and menopausal symptoms such as hot flashes, fatigue and irritability also improved. The authors report no affiliation with the extract's maker.
View study: Mishra et al. (2026), opens in a new tab
Gudise et al. (2024)Aspurūs™
Cureus 2024;16(4):e57879
View study: Gudise et al. (2024), opens in a new tab
Exact ingredient: Shatavari 5% extract · Exact standardization (500 mg/day)
Compared with placebo, the extract reduced hot flashes, night sweats, insomnia, anxiety, nervousness, vaginal dryness and loss of libido, and improved Utian quality-of-life scores, with no significant adverse events.
- RCT, double-blind
- n=70
- 5% total Shatavarins
- 500 mg/day
- 60 days
Full summary
A double-blind, multicenter, randomized, placebo-controlled trial in 70 women aged 40-65 with menopausal symptoms used a Shatavari root extract standardized to 5% total Shatavarins (HPTLC) at 250 mg twice daily (500 mg/day) for 60 days. Compared with placebo, the extract reduced hot flashes, night sweats, insomnia, anxiety, nervousness, vaginal dryness and loss of libido, and improved Utian quality-of-life scores, with no significant adverse events.
View study: Gudise et al. (2024), opens in a new tab

Show 4 more studies

Mahajan et al. (2025)SRI-81
Int J Womens Health 2025;17:4057-4073
View study: Mahajan et al. (2025), opens in a new tab
Related extract: Shatavari · Related extract (>10% total Shatavarins)
The extract significantly improved Menopause Rating Scale domains, perceived stress and hot flashes versus placebo; estradiol, FSH and T3 levels rose, and no adverse effects on liver or kidney function were observed.
- RCT, double-blind
- n=80
- >10% Shatavarins
- 300 mg/day
- 8 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 80 perimenopausal women (73 per-protocol) tested 300 mg/day of SRI-81 Shatavari root extract, standardized to >10% total Shatavarins, for 8 weeks. The extract significantly improved Menopause Rating Scale domains, perceived stress and hot flashes versus placebo; estradiol, FSH and T3 levels rose, and no adverse effects on liver or kidney function were observed.
View study: Mahajan et al. (2025), opens in a new tab
Mhatre et al. (2026)SRI-81
Front Endocrinol (Lausanne) 2026;17:1769773
View study: Mhatre et al. (2026), opens in a new tab
Related extract: Shatavari · Related extract (>10% total Shatavarins)
Versus placebo, it reduced perceived stress and follicular count and increased endometrial thickness, and no serious adverse events occurred.
- RCT, double-blind
- n=70
- >10% Shatavarins
- 300 mg/day
- 12 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 70 women aged 20-40 with PCOS (66 completed) tested 300 mg/day of SRI-81 Shatavari root extract for 12 weeks. Versus placebo, it reduced perceived stress and follicular count and increased endometrial thickness; ovarian volume, BMI, hormone levels and other laboratory values were similar between groups, and no serious adverse events occurred.
View study: Mhatre et al. (2026), opens in a new tab
Chattopadhyay et al. (2026)SheVari4®
Food Nutr Res 2026;70:14275
View study: Chattopadhyay et al. (2026), opens in a new tab
Related extract: Shatavari · Branded extract (Shatavarin IV-focused)
Menopause-specific quality of life (MENQOL) improved by 42.8% versus placebo across vasomotor, psychosocial, physical and sexual domains; estradiol rose 36.44% while FSH fell 38.18% and cortisol 26.87%.
- RCT, double-blind
- n=60
- 100 mg/day
- 8 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 60 pre-, peri- and post-menopausal women tested 100 mg/day of the proprietary Shatavari root extract SheVari4® for 8 weeks. Menopause-specific quality of life (MENQOL) improved by 42.8% versus placebo across vasomotor, psychosocial, physical and sexual domains; estradiol rose 36.44% while FSH fell 38.18% and cortisol 26.87%.
View study: Chattopadhyay et al. (2026), opens in a new tab
Swaroop & Swaroop (2026)SheVari4®
Cureus 2026;18(4):e106987
View study: Swaroop & Swaroop (2026), opens in a new tab
Related extract: Shatavari · Branded extract (Shatavarin IV-focused)
In the SheVari4® group, Menopause Rating Scale scores fell 43% by week 4 and 71% by week 8, a significant difference from placebo (p<0.001), with adverse events mild and comparable between groups.
- RCT, double-blind
- n=60
- 100 mg/day
- 8 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 60 healthy women aged 40-55 tested 100 mg/day of SheVari4® Shatavari root extract. In the SheVari4® group, Menopause Rating Scale scores fell 43% by week 4 and 71% by week 8, a significant difference from placebo (p<0.001), with adverse events mild and comparable between groups.
View study: Swaroop & Swaroop (2026), opens in a new tab

Evidence note

At the label use of 2 capsules a day, HerB™ provides 250 mg of 5% Shatavarin extract (the same standardization and daily dose as the ARova5X trial), 250 mg of 40% Shatavari extract, 590 mg of Shatavari root powder, 400 mg of Ashoka bark extract (5% tannins) and 10 mg of 95% black pepper extract. The Gudise et al. trial used the same 5% standardization at 500 mg/day. SRI-81 (>10% total Shatavarins) and SheVari4® are related Shatavari root extracts that add further clinical support. For Ashoka bark, traditional Ayurvedic use supports its historical role in women's wellness formulations.

Customer reviews

No reviews yet

Bought HerB™ Capsules? Tell us how it went. We only publish genuine reviews, and only with your permission.

Write a review

Questions, answered

One serving is 1 capsule (750 mg). Each bottle holds 60 capsules, which is 60 servings.

Zoom

60 · Vegan

HerB™ Capsules

Shatavari and Ashoka bark, to help regulate cycles and ease monthly discomfort, naturally.

₹1,395

60 vegan capsules · 60 servings

Purchase

One-time purchase₹1,395

Subscribe & Save15% off every order₹1,395₹1,186

30-day assurance · Free shipping above ₹499

Supports hormonal balanceHelps support natural hormonal harmony.
Supports reproductive healthNourishes and strengthens women’s reproductive wellness.
Helps regulate menstrual cycleSupports regular, healthy cycles.
Promotes menstrual comfortHelps ease monthly discomfort naturally.
Nourishes from withinPowerful herbs that nourish and support women’s wellness holistically.
Gentle and plant-basedPlant-based, clean and gentle for everyday use.

Shatavari root powder295 mg
Ashoka bark extract200 mg
Shatavari root extract125 mg
Shatavari root extract125 mg
Black pepper extract5 mg

Full composition

Suggested serving: 1 capsule (750 mg) · 60 servings per bottle

Delivery estimate

Delivery pincode

Enter your pincode to see estimated delivery dates

Make Periods Easier Again

The label, in full

One serving is 1 capsule (750 mg). Every bottle holds 60 capsules, 60 servings.

shatavarins I–IV: 5%
Shatavari saponins: 40%
Ashoka bark tannins: 5%

GMO free
Vegan
Standardised extracts
Plant-based HPMC capsule

Supplement FactsServing size 1 capsule (750 mg)Servings per container 60
Ingredient	Amount per serving
Shatavari root powderAsparagus racemosus	295 mg
Ashoka bark extractSaraca indica · 5% tanninsSupports uterine tone and comfort.	200 mg
Shatavari root extractAsparagus racemosus · 5% shatavarins I–IVWorks with the 40% extract toward hormonal balance and reproductive strength.	125 mg
Shatavari root extractAsparagus racemosus · 40% saponins	125 mg
Black pepper extractPiper nigrum · 95% extract	5 mg
Other ingredients: Capsule shell, plant-based (HPMC)

Complete women’s wellness support

Supports hormonal balance
Helps support natural hormonal harmony.
Supports reproductive health
Nourishes and strengthens women’s reproductive wellness.
Helps regulate menstrual cycle
Supports regular, healthy cycles.
Promotes menstrual comfort
Helps ease monthly discomfort naturally.
Nourishes from within
Powerful herbs that nourish and support women’s wellness holistically.
Gentle and plant-based
Plant-based, clean and gentle for everyday use.

Research

Research on this product

Evidence strengthModerate

Moderate for Shatavari; Ashoka is backed by traditional Ayurvedic use.

Supported by 6 double-blind RCTs with 554 participants, all published 2024-2026, including 2 on the same 5% total-shatavarin standardization.

Human RCTs: 6; 2 on the same 5% standardization (284 participants)
Participants in RCTs: 554
Other studies: None

See all research

Studies

6 studies

Mishra et al. (2026)ARova5X
Avicenna J Phytomed 2026;16(5):860-872
View study: Mishra et al. (2026), opens in a new tab
Exact ingredient: Shatavari 5% extract · Exact match (standardization and daily dose)
Versus placebo, the extract improved sexual-function domains including desire, arousal and satisfaction; vaginal lubrication improved by 84.11% in the extract group versus 13.08% on placebo, and oxidative-stress markers and menopausal symptoms such as hot flashes, fatigue and irritability also improved.
- RCT, double-blind
- n=214
- 5% shatavarins
- 250 mg/day
- 90 days
Full summary
A randomized, double-blind, placebo-controlled trial in 214 postmenopausal women (107 per group) tested a hydroalcoholic Shatavari root extract standardized to 5% shatavarins at 250 mg/day for 90 days. Versus placebo, the extract improved sexual-function domains including desire, arousal and satisfaction; vaginal lubrication improved by 84.11% in the extract group versus 13.08% on placebo, and oxidative-stress markers and menopausal symptoms such as hot flashes, fatigue and irritability also improved. The authors report no affiliation with the extract's maker.
View study: Mishra et al. (2026), opens in a new tab
Gudise et al. (2024)Aspurūs™
Cureus 2024;16(4):e57879
View study: Gudise et al. (2024), opens in a new tab
Exact ingredient: Shatavari 5% extract · Exact standardization (500 mg/day)
Compared with placebo, the extract reduced hot flashes, night sweats, insomnia, anxiety, nervousness, vaginal dryness and loss of libido, and improved Utian quality-of-life scores, with no significant adverse events.
- RCT, double-blind
- n=70
- 5% total Shatavarins
- 500 mg/day
- 60 days
Full summary
A double-blind, multicenter, randomized, placebo-controlled trial in 70 women aged 40-65 with menopausal symptoms used a Shatavari root extract standardized to 5% total Shatavarins (HPTLC) at 250 mg twice daily (500 mg/day) for 60 days. Compared with placebo, the extract reduced hot flashes, night sweats, insomnia, anxiety, nervousness, vaginal dryness and loss of libido, and improved Utian quality-of-life scores, with no significant adverse events.
View study: Gudise et al. (2024), opens in a new tab

Show 4 more studies

Mahajan et al. (2025)SRI-81
Int J Womens Health 2025;17:4057-4073
View study: Mahajan et al. (2025), opens in a new tab
Related extract: Shatavari · Related extract (>10% total Shatavarins)
The extract significantly improved Menopause Rating Scale domains, perceived stress and hot flashes versus placebo; estradiol, FSH and T3 levels rose, and no adverse effects on liver or kidney function were observed.
- RCT, double-blind
- n=80
- >10% Shatavarins
- 300 mg/day
- 8 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 80 perimenopausal women (73 per-protocol) tested 300 mg/day of SRI-81 Shatavari root extract, standardized to >10% total Shatavarins, for 8 weeks. The extract significantly improved Menopause Rating Scale domains, perceived stress and hot flashes versus placebo; estradiol, FSH and T3 levels rose, and no adverse effects on liver or kidney function were observed.
View study: Mahajan et al. (2025), opens in a new tab
Mhatre et al. (2026)SRI-81
Front Endocrinol (Lausanne) 2026;17:1769773
View study: Mhatre et al. (2026), opens in a new tab
Related extract: Shatavari · Related extract (>10% total Shatavarins)
Versus placebo, it reduced perceived stress and follicular count and increased endometrial thickness, and no serious adverse events occurred.
- RCT, double-blind
- n=70
- >10% Shatavarins
- 300 mg/day
- 12 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 70 women aged 20-40 with PCOS (66 completed) tested 300 mg/day of SRI-81 Shatavari root extract for 12 weeks. Versus placebo, it reduced perceived stress and follicular count and increased endometrial thickness; ovarian volume, BMI, hormone levels and other laboratory values were similar between groups, and no serious adverse events occurred.
View study: Mhatre et al. (2026), opens in a new tab
Chattopadhyay et al. (2026)SheVari4®
Food Nutr Res 2026;70:14275
View study: Chattopadhyay et al. (2026), opens in a new tab
Related extract: Shatavari · Branded extract (Shatavarin IV-focused)
Menopause-specific quality of life (MENQOL) improved by 42.8% versus placebo across vasomotor, psychosocial, physical and sexual domains; estradiol rose 36.44% while FSH fell 38.18% and cortisol 26.87%.
- RCT, double-blind
- n=60
- 100 mg/day
- 8 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 60 pre-, peri- and post-menopausal women tested 100 mg/day of the proprietary Shatavari root extract SheVari4® for 8 weeks. Menopause-specific quality of life (MENQOL) improved by 42.8% versus placebo across vasomotor, psychosocial, physical and sexual domains; estradiol rose 36.44% while FSH fell 38.18% and cortisol 26.87%.
View study: Chattopadhyay et al. (2026), opens in a new tab
Swaroop & Swaroop (2026)SheVari4®
Cureus 2026;18(4):e106987
View study: Swaroop & Swaroop (2026), opens in a new tab
Related extract: Shatavari · Branded extract (Shatavarin IV-focused)
In the SheVari4® group, Menopause Rating Scale scores fell 43% by week 4 and 71% by week 8, a significant difference from placebo (p<0.001), with adverse events mild and comparable between groups.
- RCT, double-blind
- n=60
- 100 mg/day
- 8 weeks
Full summary
A randomized, double-blind, placebo-controlled trial in 60 healthy women aged 40-55 tested 100 mg/day of SheVari4® Shatavari root extract. In the SheVari4® group, Menopause Rating Scale scores fell 43% by week 4 and 71% by week 8, a significant difference from placebo (p<0.001), with adverse events mild and comparable between groups.
View study: Swaroop & Swaroop (2026), opens in a new tab

Evidence note

Customer reviews

No reviews yet

Bought HerB™ Capsules? Tell us how it went. We only publish genuine reviews, and only with your permission.

Write a review

Questions, answered

One serving is 1 capsule (750 mg). Each bottle holds 60 capsules, which is 60 servings.

HerB™ Capsules

Make Periods Easier Again

The label, in full

Complete women’s wellness support

Supports hormonal balance

Supports reproductive health

Helps regulate menstrual cycle

Promotes menstrual comfort

Nourishes from within

Gentle and plant-based

Research on this product

Studies

Mishra et al. (2026)ARova5X

Gudise et al. (2024)Aspurūs™

Mahajan et al. (2025)SRI-81

Mhatre et al. (2026)SRI-81

Chattopadhyay et al. (2026)SheVari4®

Swaroop & Swaroop (2026)SheVari4®

Customer reviews

Questions, answered

How do I take HerB™ Capsules?

What is in each serving?

Is it vegan?

Is there research behind it?

Can I take it if I am pregnant, nursing or on medication?

HerB™ Capsules

Make Periods Easier Again

The label, in full

Complete women’s wellness support

Supports hormonal balance

Supports reproductive health

Helps regulate menstrual cycle

Promotes menstrual comfort

Nourishes from within

Gentle and plant-based

Research on this product

Studies

Mishra et al. (2026)ARova5X

Gudise et al. (2024)Aspurūs™

Mahajan et al. (2025)SRI-81

Mhatre et al. (2026)SRI-81

Chattopadhyay et al. (2026)SheVari4®

Swaroop & Swaroop (2026)SheVari4®

Customer reviews

Questions, answered

How do I take HerB™ Capsules?

What is in each serving?

Is it vegan?

Is there research behind it?

Can I take it if I am pregnant, nursing or on medication?